GuidelineAmerican journal of respiratory and critical care medicine2022
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
3 registry-linked trialsOpen access · greenAbstract readPractice Guideline
In one paragraph
Guideline in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,643 papers, 8 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1,643citing papers in PubMed, 8 pooled it
345.7field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT06844331 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation
ULtrasOund Applicability in the Assessment of Patients With fibRosing Interstitial Lung Disease (LORD): A Research Protocol of a Single Center, Real-life, Prospective Observational Study
"Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease and Its Relation to Disease Activity"
Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis
Who cites it
1,643 citing papers in PubMed, 8 syntheses or guidelines pooled it, 2,431 citations in OpenAlex.
- Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review.BMJ open respiratory research · 2026Pooled it
- Prevalence and incidence of interstitial lung diseases in systemic lupus erythematosus: systematic review and meta-analyses.Lupus science & medicine · 2026Pooled it
- Comorbidities in clinical cohorts of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026Pooled it
- Prevalence of anxiety and depression in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.BMC pulmonary medicine · 2026Pooled it
- BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic review.BMJ open respiratory research · 2026Pooled it
- Economic burden and cost drivers of interstitial lung disease: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Pooled it
- Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use.PharmacoEconomics · 2026Pooled it
- Outcomes of patients with acute exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids: a systematic review and meta-analysis.Respiratory research · 2026Pooled it
- Pharmacokinetics and Safety of Nerandomilast in Healthy Volunteers.European journal of drug metabolism and pharmacokinetics · 2026Trial
- Pamufetinib (TAS-115) for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trial.American journal of respiratory and critical care medicine · 2026Trial
- Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial.The European respiratory journal · 2026Trial
- Integrated machine learning risk model for predicting radiation pneumonitis in lung cancer patients with interstitial lung disease.Annals of medicine · 2026Article
- Injectable microsphere-based delivery strategies for stem cells and their derivatives in tissue regeneration.Bioactive materials · 2026Review
- The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.Arthritis care & research · 2026Review
- Comparative study on mouse models of acute exacerbation of pulmonary fibrosis.Experimental and therapeutic medicine · 2026Article
- Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study.Rheumatology international · 2026Article
- Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.Animal models and experimental medicine · 2026Article
- Review of the Impact of Weight Loss and Body Mass Index in Clinical Trials of Nintedanib in Interstitial Lung Disease.Advances in therapy · 2026Article
- Shared and Disease-Preferential Matrisome Programs in Fibrosing Interstitial Lung Disease: Evidence from Cross-Cohort and Within-Cohort Analysis.Current issues in molecular biology · 2026Article
- Assessment of fibrosing interstitial lung disease progression: CT visual score on radiological progressive pulmonary fibrosis criteria versus 3D-CT volume-histogram analysis.Japanese journal of radiology · 2026Article
1,583 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
41 authors.
Ganesh RaghuORCID 0000-0001-7506-6643
Martine Remy-JardinORCID 0000-0003-1944-4288
Luca RicheldiORCID 0000-0001-8594-1448
Carey C ThomsonORCID 0000-0002-5861-0683
Yoshikazu InoueORCID 0000-0003-3994-874X
Takeshi JohkohORCID 0000-0003-1237-2349
Michael KreuterORCID 0000-0003-4402-2159
David A LynchORCID 0000-0002-6329-2325
Toby M MaherORCID 0000-0001-7192-9149
Fernando J MartinezORCID 0000-0002-2412-3182
Maria Molina-MolinaORCID 0000-0002-1852-1723
Jeffrey L MyersORCID 0000-0001-8247-3028
Andrew G Nicholson
Christopher J Ryerson
Mary E StrekORCID 0000-0002-7671-1023
Lauren K TroyORCID 0000-0002-7426-336X
Marlies WijsenbeekORCID 0000-0002-4527-6962
Manoj J MammenORCID 0000-0003-0343-3234
Tanzib HossainORCID 0000-0002-1995-7828
Brittany D BissellORCID 0000-0002-7345-9731
Derrick D Herman
Stephanie M HonORCID 0000-0002-0390-8407
Fayez Kheir
Yet H KhorORCID 0000-0002-5434-9342
Madalina MacreaORCID 0000-0002-5352-9587
Katerina M Antoniou
Demosthenes Bouros
Ivette Buendia-RoldanORCID 0000-0002-2825-506X
Fabian CaroORCID 0000-0003-2484-1923
Bruno CrestaniORCID 0000-0002-2961-3455
Lawrence Ho
Julie Morisset
Amy L OlsonORCID 0000-0002-5368-0412
Anna PodolanczukORCID 0000-0002-9559-1485
Venerino Poletti
Moisés SelmanORCID 0000-0002-1022-4783
Thomas Ewing
Stephen Jones
Shandra L KnightORCID 0000-0002-4404-3833
Marya GhazipuraORCID 0000-0003-4328-6822
Kevin C WilsonORCID 0000-0003-4429-2263
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Idiopathic Pulmonary FibrosisLung Diseases, InterstitialAntacidsBiopsyHumansLungUnited StatesAntacidshistopathologyidiopathic pulmonary fibrosisprogressive pulmonary fibrosisradiology
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.